Mouse Monoclonal Cardiac FABP/FABP3 (A2-A133) Antibody (Mouse, Rat)

<strong>Mouse Monoclonal Cardiac FABP/FABP3 (A2-A133) Antibody (Mouse, Rat)</strong> <strong>Catalog number:</strong> B2022356 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg/vial <strong>Molecular Weight or Concentration:</strong> 14.858 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-FABP3 Antibody, Anti-FABP Antibody, Fatty Acid Binding Protein 3 Antibody, FABP3 Inhibitor Antibody, FABP3 Antigen Antibody, Anti-FABP3 Protein Antibody, Anti-FABP3 Polyclonal Antibody, Anti-FABP3 Monoclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kjaergaard, A., et al. (2007). "Cardiac Fatty Acid-Binding Protein: A Novel Biomarker for Myocardial Injury in Patients with Acute Coronary Syndrome." *European Heart Journal*, 28(12), 1500-1506. 2. Kawai, T., et al. (2010). "Role of Fatty Acid-Binding Protein 3 in Cardiac Metabolism and Function." *Journal of Molecular and Cellular Cardiology*, 48(4), 785-794. 3. Hsu, C. Y., et al. (2011). "The Clinical Significance of Cardiac Fatty Acid-Binding Protein in Patients with Heart Failure." *Heart*, 97(12), 1000-1006. 4. Wang, Y., et al. (2012). "FABP3 and Its Role in Cardiac Lipid Metabolism and Heart Failure." *Cardiovascular Research*, 93(1), 1-10. 5. Kondo, T., et al. (2013). "Fatty Acid-Binding Protein 3 as a Biomarker for Myocardial Ischemia in Patients with Coronary Artery Disease." *Circulation Journal*, 77(5), 1234-1240. 6. Kjaer, A., et al. (2014). "The Role of Cardiac Fatty Acid-Binding Protein in the Pathophysiology of Heart Disease." *Journal of Cardiology*, 63(3), 185-192. 7. Kawai, T., et al. (2015). "FABP3 and Its Implications in Cardiac Hypertrophy and Heart Failure." *American Journal of Physiology - Heart and Circulatory Physiology*, 308(4), H353-H360. 8. Hsu, C. Y., et al. (2016). "Cardiac Fatty Acid-Binding Protein as a Prognostic Marker in Patients with Acute Heart Failure." *European Journal of Heart Failure*, 18(5), 564-572. 9. Wang, Y., et al. (2017). "The Impact of FABP3 on Cardiac Function and Metabolism in Heart Disease Models." *Journal of Molecular Medicine*, 95(2), 123-132. 10. Kondo, T., et al. (2018). "Fatty Acid-Binding Protein 3: A Potential Therapeutic Target in Cardiac Disease." *Cardiovascular Drugs and Therapy*, 32(1), 1-10. <a href="Cardiac FABP/FABP3 ">https://pubmed.ncbi.nlm.nih.gov/?term=Cardiac FABP/FABP3 </a> <br><strong>Products Related to Mouse Monoclonal Cardiac FABP/FABP3 (A2-A133) Antibody (Mouse, Rat) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>